M&G PLC Increases Holdings in Kenvue Inc. $KVUE

M&G PLC increased its position in Kenvue Inc. (NYSE:KVUE) by 18.8% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,173,365 shares of the company’s stock after acquiring an additional 1,292,711 shares during the period. M&G PLC owned approximately 0.43% of Kenvue worth $171,641,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Trust Co. of Vermont increased its position in shares of Kenvue by 266.8% in the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock valued at $33,000 after buying an additional 1,150 shares in the last quarter. Truvestments Capital LLC acquired a new stake in Kenvue in the 1st quarter valued at about $37,000. Clal Insurance Enterprises Holdings Ltd increased its holdings in Kenvue by 378.5% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company’s stock valued at $39,000 after acquiring an additional 1,287 shares in the last quarter. Bank Julius Baer & Co. Ltd Zurich raised its position in Kenvue by 120.6% during the first quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,699 shares of the company’s stock worth $41,000 after acquiring an additional 929 shares during the last quarter. Finally, First Pacific Financial purchased a new stake in shares of Kenvue in the second quarter valued at about $54,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

KVUE has been the subject of a number of recent research reports. Zacks Research upgraded Kenvue to a “strong sell” rating in a research report on Monday, August 11th. The Goldman Sachs Group cut their price target on Kenvue from $22.00 to $19.00 and set a “neutral” rating for the company in a report on Thursday, October 2nd. Jefferies Financial Group decreased their price objective on Kenvue from $25.00 to $23.00 and set a “buy” rating on the stock in a research note on Monday, October 27th. Barclays boosted their target price on shares of Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a research note on Monday. Finally, Royal Bank Of Canada decreased their price target on shares of Kenvue from $24.00 to $22.00 and set a “sector perform” rating on the stock in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, twelve have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $20.23.

Kenvue Price Performance

Kenvue stock opened at $16.75 on Wednesday. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. The firm has a 50 day moving average price of $16.61 and a 200 day moving average price of $20.17. The company has a market cap of $32.09 billion, a price-to-earnings ratio of 22.33, a PEG ratio of 2.45 and a beta of 0.71.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. The company had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.83 billion. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. Kenvue’s revenue for the quarter was down 3.5% on a year-over-year basis. During the same quarter last year, the business earned $0.28 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Sell-side analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th will be paid a dividend of $0.2075 per share. The ex-dividend date is Wednesday, November 12th. This represents a $0.83 annualized dividend and a yield of 5.0%. Kenvue’s dividend payout ratio is currently 110.67%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.